Challenges and Opportunities While Developing a Group A Meningococcal Conjugate Vaccine Within a Product Development Partnership: A Manufacturer's Perspective From the Serum Institute of India (Q26778263)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Challenges and Opportunities While Developing a Group A Meningococcal Conjugate Vaccine Within a Product Development Partnership: A Manufacturer's Perspective From the Serum Institute of India |
scientific article |
Statements
Challenges and Opportunities While Developing a Group A Meningococcal Conjugate Vaccine Within a Product Development Partnership: A Manufacturer's Perspective From the Serum Institute of India (English)
0 references
15 November 2015
4 references
20 June 2019
19 September 2019
24 January 2021
16 July 2021
4 references
20 June 2019
19 September 2019
24 January 2021
16 July 2021
61 Suppl 5
0 references
suppl 5
0 references
S483-8
0 references
4 references
20 June 2019
19 September 2019
24 January 2021
16 July 2021
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference